Trials / Completed
CompletedNCT00913952
To Demonstrate the Relative Bioavailability of Geneva and Basel (Anafranil) 25 mg Clomipramine Hydrochloride Capsules Under Fed and Fasted Conditions
Comparative, Randomized, 3-way Crossover Bioavailability Study of Geneva and Basel (Anafranil) 25 mg Clomipramine Hydrochloride Capsules In Health Adult Males Under Fed and Fasted Conditions
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 18 (actual)
- Sponsor
- Sandoz · Industry
- Sex
- Male
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
To demonstrate the relative bioavailability of Geneva and Basel (Anafranil) 25 mg Clomipramine Hydrochloride capsules under fed and fasted conditions.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Geneva 25 mg Clomipramine Hydrochloride Capsules Under Fasting Conditions | |
| DRUG | Geneva 25 mg Clomipramine Hydrochloride Capsules Under Fed Conditions | |
| DRUG | Basel (Anafranil) 25 mg Clomipramine Hydrochloride Capsules Under Fed Conditions |
Timeline
- Start date
- 1994-04-01
- Primary completion
- 1994-06-01
- Completion
- 1994-06-01
- First posted
- 2009-06-04
- Last updated
- 2017-03-28
Source: ClinicalTrials.gov record NCT00913952. Inclusion in this directory is not an endorsement.